Thomas D. Reed, Chief Science Officer at INTREXON CORP (XON), bought 1,855 shares at $16.00 ($29K) on 2013-08-13, disclosed to the SEC on 2013-08-15.
Open-market purchase of $29k XON by Chief Science Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 55 | $0 | 0.0% |
| 2 | $16.00 | 1,800 | $29K | 100.0% |
| Total | $15.53 avg | 1,855 | $29K | 100% |
| Filing → |
| XON | SELL | 2020-01-03 | $20K | — | Filing → |
| XON | SELL | 2019-10-02 | $20K | — | Filing → |
| XON | SELL | 2019-07-02 | $27K | — | Filing → |